Tag: NASD:IOVA

US Equity Markets

Strong Q2 2024 Results Propel Iovance (IOVA) Stock

On Friday, investor confidence in shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) increased significantly. After the firm released its Financial Results and Corporate Updates for the second quarter of 2024, that resulted in a price increase of 24.94%. The stock

Comet Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.